Last updated: April 25, 2026
Who Supplies Tasigna (nilotinib) for Manufacturers and End-Users?
Tasigna is a branded form of nilotinib. Supply chains for Tasigna fall into two buckets: (1) the branded product supply chain (Novartis and its partners) and (2) generic nilotinib supply chains. Patent status and market history govern which manufacturers can legally supply each bucket.
Who manufactures the branded drug (Tasigna) supply?
Tasigna’s branded manufacturer is Novartis. The branded supply is produced under Novartis-controlled manufacturing and quality systems and distributed through Novartis and authorized distribution channels in each market.
Regulatory reference points
- Originator name: Tasigna (nilotinib) is marketed by Novartis under drug application pathways controlled by the originator entity in each jurisdiction.
- Drug substance: nilotinib (active pharmaceutical ingredient, API).
Who supplies generic nilotinib (alternative supply)
Generic manufacturers do not “supersede” branded Tasigna; they supply generic nilotinib products marketed in the same therapeutic space. In most markets, generic access begins after relevant exclusivity and patent protections expire, subject to local regulatory approvals.
Generic nilotinib supply typically includes:
- API suppliers providing nilotinib to formulation manufacturers.
- Finished dose manufacturers producing generic tablets/capsules.
- Market authorizations and local distributors for each country.
Because you asked for “Suppliers for the pharmaceutical drug: tasigna,” the critical distinction is that Tasigna-branded supply is tied to Novartis, while supplier lists for “nilotinib” generics vary by country, listing year, and regulatory approval status.
What supply inputs exist for tasigna-like nilotinib products?
For drug product manufacturing, the supply chain has two repeatable layers:
| Supply layer |
What it supplies |
Typical commercial counterpart |
| API |
Nilotinib active ingredient |
API producer(s) licensed/qualified for drug development and GMP use |
| Drug product |
Formulated nilotinib dosage form |
Tablet/capsule finished dose manufacturer and packaging site(s) |
Supply chain map for decision-making
Use this map to classify “supplier” conversations correctly:
| Decision use-case |
Supplier class that matters |
| Securing branded Tasigna units |
Novartis distribution and authorized channels |
| Building inventory for nilotinib competition |
Generic nilotinib manufacturers in target market |
| Ensuring formulation continuity |
Finished dose manufacturers and packaging sites |
| Reducing reliance risk |
API suppliers qualified across multiple finished dose contracts |
Regulatory and market constraints that define supplier eligibility
Supplier eligibility for nilotinib depends on two controls:
- Patent and exclusivity landscape for nilotinib in the target jurisdiction
- Marketing authorization for the finished product (generic or branded)
Tasigna is a branded product of nilotinib under Novartis. Generic nilotinib supply is enabled only when legally approved products enter the market.
Key Takeaways
- Branded Tasigna supply is Novartis-controlled and distributed through authorized channels in each market.
- Alternative supply is generic nilotinib from multiple finished dose manufacturers and their qualified API sources, with availability driven by country-specific regulatory approvals and patent/exclusivity status.
- A complete “supplier list” must be scoped to (a) branded Tasigna vs (b) generic nilotinib and to (c) the specific market/country because supplier rosters vary by regulatory approvals and distribution authorizations.
FAQs
-
Is Tasigna manufactured by Novartis or generic companies?
Tasigna (branded nilotinib) is a Novartis product; generic companies supply generic nilotinib when approved.
-
Do API suppliers for nilotinib also supply Tasigna?
API suppliers can support nilotinib drug product manufacturing, but Tasigna supply is managed under Novartis’s branded supply chain and qualified manufacturer framework.
-
Can I buy Tasigna from generic nilotinib suppliers?
You can buy generic nilotinib, not branded Tasigna, unless the seller is distributing branded Tasigna through authorized channels.
-
Are supplier lists the same worldwide?
No. Finished dose availability and distribution vary by country based on marketing authorization and patent/exclusivity outcomes.
-
What matters most for securing supply?
The fastest path is to specify whether you need branded Tasigna or generic nilotinib and then target suppliers authorized for that specific market.
References
[1] U.S. Food and Drug Administration. Tasigna (nilotinib) prescribing information and product labeling. FDA label database.
[2] European Medicines Agency. Tasigna (nilotinib) product information. EMA medicines database.
[3] Novartis. Tasigna (nilotinib) product information. Company product pages and patient/professional prescribing materials.
